Clinical Trial: A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07464119) titled 'A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy' on March 04.

Brief Summary: This is a single-arm, open-label clinical trial designed to assess the safety and therapeutic efficacy of iPSC-derived islet cell infusion in patients with diabetes mellitus.

Study Start Date: March 16

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus

Intervention: BIOLOGICAL: iPSC-derived islet cell

iPSC-derived islet cell infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Peking University First Hospital

Information provided by (Responsible Party): Zhang Junqing, Peking University First Hospital

Published...